Sushil Patel
Chief Executive Officer at REPLIMUNE GROUP, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Dr. Sushil Patel is an Independent Director at Revolution Medicines, Inc. and a Chief Executive Officer & Director at Replimune Group, Inc. He is on the Board of Directors at Revolution Medicines, Inc. and Replimune Group, Inc. Dr. Patel was previously employed as a Vice President-Franchise & Head-Oncology by Genentech, Inc. He received his undergraduate degree from the University of Warwick, a graduate degree from Imperial College London and a doctorate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.38% | 2024-03-31 | 232,208 ( 0.38% ) | 1 M $ | 2024-04-29 |
| 2024-04-09 | 15,700 ( 0.01% ) | 554 681 $ | 2024-04-29 |
Sushil Patel active positions
| Companies | Position | Start |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 2024-03-31 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 2022-06-15 |
Former positions of Sushil Patel
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2021-04-30 |
Training of Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sushil Patel
